Browsing ImmunoConcEpT - UMR 5164 by Author "VEILLON, Remi"
Now showing items 1-5 of 5
-
The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours
HAIK, Laura; GONTHIER, Aurore; QUIVY, Amandine ...(Acta Oncologica. vol. 60, n° 12, pp. 1597-1603, 2021-09-22)Article de revue -
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors
GEFARD-GONTIER, Emilie; MARKICH, Romane; ZYSMAN, Maeva ...(Cancer Immunology, Immunotherapy. vol. 71, n° 11, pp. 2609-2618, 2022-11)Article de revue -
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
LADOUCEUR, Alexandra; BARNETCHE, Thomas; MOUTERDE, G. ...(RMD Open. vol. 9, n° 4, 2023)Article de revueOpen access -
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
ROSELLINI, Pietro; AMINTAS, Samuel; CAUMONT, Charline ...(European Journal of Cancer. vol. 172, pp. 85-95, 2022-09)Article de revue -
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
ROSELLINI, Pietro; AMINTAS, Samuel; CAUMONT, Charline ...(European Journal of Cancer. vol. 172, pp. 85-95, 2022-06-24)Article de revue